SEC Form 4 · accession 0001209191-15-045586
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Denise Gilbert
Director
Period of report
May 20, 2015
Accepted (ET)
May 21, 2015 · 6:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.21 | May 20, 2015 | A | 20,000 | A | — | May 20, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1This option shall vest and become exercisable in 12 equal monthly installments and shall become fully vested on May 20, 2016.